STOCK TITAN

Beth Hecht 10b5-1 sales reported for XERS (NASDAQ: XERS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

XERS filed a Form 144 reporting Rule 144 sales by Beth P. Hecht. The notice lists two 10b5-1 sales of 16,667 common shares each on 01/02/2026 and 02/02/2026, with gross proceeds of $123,775.48 and $124,147.15 respectively. The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the XERS Form 144 disclose about insider sales?

The Form 144 disclosed two 10b5-1 sales by Beth P. Hecht of 16,667 shares each. The entries show sales on 01/02/2026 and 02/02/2026 with proceeds of $123,775.48 and $124,147.15 respectively.

Who executed the trades reported in the XERS Form 144?

The trades were executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists that broker and the address shown alongside the 10b5-1 sales entries.

Were the sales reported as 10b5-1 plan transactions in the XERS filing?

Yes. The Form 144 entries are labeled as 10b5-1 sales for Beth P. Hecht, indicating the reported transactions were executed under a trading plan established under Rule 10b5-1.

How many total shares did Beth P. Hecht sell according to this Form 144?

The filing lists two sales of 16,667 common shares each, totaling 33,334 shares reported in the provided excerpt. Each sale includes its gross proceeds amount in dollars.

Does the Form 144 state who received the sale proceeds?

The excerpt shows gross proceeds amounts for each sale but does not state the recipient of proceeds beyond identifying the selling person. The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services.
Xeris Biopharma Holdings

NASDAQ:XERS

XERS Rankings

XERS Latest News

XERS Latest SEC Filings

XERS Stock Data

1.02B
159.28M
Biotechnology
Pharmaceutical Preparations
Link
United States
CHICAGO